Page last updated: 2024-09-05

sb 203580 and Friedreich Disease

sb 203580 has been researched along with Friedreich Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cotticelli, MG; Kaur, A; Lin, D; Ruff, E; Tobias, JW; Wang, Y; Wilson, RB; Xia, S	1

Other Studies

1 other study(ies) available for sb 203580 and Friedreich Disease

Article	Year
Identification of p38 MAPK as a novel therapeutic target for Friedreich's ataxia. Scientific reports, 2018, 03-22, Volume: 8, Issue:1 Topics: Cells, Cultured; Computational Biology; Enzyme Inhibitors; Fibroblasts; Frataxin; Friedreich Ataxia; Gene Expression Profiling; Gene Knockdown Techniques; Humans; Imidazoles; Iron-Binding Proteins; Mitogen-Activated Protein Kinase 14; Phosphorylation; Primary Cell Culture; Pyridines; RNA, Small Interfering; Signal Transduction	2018

Article

Year

Identification of p38 MAPK as a novel therapeutic target for Friedreich's ataxia.

Scientific reports, 2018, 03-22, Volume: 8, Issue:1

Topics: Cells, Cultured; Computational Biology; Enzyme Inhibitors; Fibroblasts; Frataxin; Friedreich Ataxia; Gene Expression Profiling; Gene Knockdown Techniques; Humans; Imidazoles; Iron-Binding Proteins; Mitogen-Activated Protein Kinase 14; Phosphorylation; Primary Cell Culture; Pyridines; RNA, Small Interfering; Signal Transduction

2018